File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1365-2125.2005.02450.x
- Scopus: eid_2-s2.0-20544460943
- PMID: 15948943
- WOS: WOS:000229580200019
- Find via
Supplementary
-
Bookmarks:
- CiteULike: 1
- Citations:
- Appears in Collections:
Article: The potential of UK clinical databases in enhancing paediatric medication research
Title | The potential of UK clinical databases in enhancing paediatric medication research |
---|---|
Authors | |
Keywords | Clinical databases Drug utilization Paediatric Pharmacovigilance UK |
Issue Date | 2005 |
Publisher | Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/BJCP |
Citation | British Journal Of Clinical Pharmacology, 2005, v. 59 n. 6, p. 750-755 How to Cite? |
Abstract | The research potential of many UK clinical databases is not being realized. A recent report published by the Royal College of Paediatrics & Child Health stated that there is a need to build research capacity and support in the area of paediatric pharmacology, with specific emphasis on the use of clinical databases. This article presents the databases available in the UK for medication research and gives some examples of paediatric studies conducted. The databases discussed include the Prescription Pricing Authority database, the General Practice Research Database, IMS Health databases (Medical Data Index, MIDAS Prescribing Insights, Disease-Analyser-Mediplus) and the Yellow Card Scheme. Other databases such as the Medicines Monitoring Unit (MEMO) and the Scottish Primary Care Computer System also have research potential in paediatric pharmacoepidemiology, but their population sizes are relatively small. © 2005 Blackwell Publishing Ltd. |
Persistent Identifier | http://hdl.handle.net/10722/132884 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 1.046 |
PubMed Central ID | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, ICK | en_HK |
dc.contributor.author | Murray, ML | en_HK |
dc.date.accessioned | 2011-04-04T07:57:46Z | - |
dc.date.available | 2011-04-04T07:57:46Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | British Journal Of Clinical Pharmacology, 2005, v. 59 n. 6, p. 750-755 | en_HK |
dc.identifier.issn | 0306-5251 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/132884 | - |
dc.description.abstract | The research potential of many UK clinical databases is not being realized. A recent report published by the Royal College of Paediatrics & Child Health stated that there is a need to build research capacity and support in the area of paediatric pharmacology, with specific emphasis on the use of clinical databases. This article presents the databases available in the UK for medication research and gives some examples of paediatric studies conducted. The databases discussed include the Prescription Pricing Authority database, the General Practice Research Database, IMS Health databases (Medical Data Index, MIDAS Prescribing Insights, Disease-Analyser-Mediplus) and the Yellow Card Scheme. Other databases such as the Medicines Monitoring Unit (MEMO) and the Scottish Primary Care Computer System also have research potential in paediatric pharmacoepidemiology, but their population sizes are relatively small. © 2005 Blackwell Publishing Ltd. | en_HK |
dc.language | eng | en_US |
dc.publisher | Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/BJCP | en_HK |
dc.relation.ispartof | British Journal of Clinical Pharmacology | en_HK |
dc.subject | Clinical databases | en_HK |
dc.subject | Drug utilization | en_HK |
dc.subject | Paediatric | en_HK |
dc.subject | Pharmacovigilance | en_HK |
dc.subject | UK | en_HK |
dc.title | The potential of UK clinical databases in enhancing paediatric medication research | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Wong, ICK: wongick@hku.hk | en_HK |
dc.identifier.authority | Wong, ICK=rp01480 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1111/j.1365-2125.2005.02450.x | en_HK |
dc.identifier.pmid | 15948943 | - |
dc.identifier.pmcid | PMC1884862 | - |
dc.identifier.scopus | eid_2-s2.0-20544460943 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-20544460943&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 59 | en_HK |
dc.identifier.issue | 6 | en_HK |
dc.identifier.spage | 750 | en_HK |
dc.identifier.epage | 755 | en_HK |
dc.identifier.isi | WOS:000229580200019 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Wong, ICK=7102513915 | en_HK |
dc.identifier.scopusauthorid | Murray, ML=7403583537 | en_HK |
dc.identifier.citeulike | 219978 | - |
dc.identifier.issnl | 0306-5251 | - |